Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr 9:5:161.
doi: 10.3389/fimmu.2014.00161. eCollection 2014.

Cancer: A Tale of Aberrant PRR Response

Affiliations
Review

Cancer: A Tale of Aberrant PRR Response

Raunaq Singh Nagi et al. Front Immunol. .
No abstract available

Keywords: cancer; inflammation; innate immunity; pattern recognition receptors; regulation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Role of PRRs in maintenance of homeostasis and cancer development. Exposure to any of the various stress stimuli leads to activation of immune system through PRRs (formula image) which results in expansion of a variety of cellular populations and production of numerous cytokines (formula image). A precise sensitive balance at the inflammatory and regulatory front eliminates and reinstates homeostasis within the host. However, under certain circumstances, the precise balance is altered due to aberrant/exaggerated inflammation or failure of regulatory mechanisms to restrict them. Such imbalance results in accumulation of cells and chemicals that deregulate the proliferative pathways; induce angiogenesis and damage the extracellular matrix, thus aiding in origin and/or progression of cancers.

References

    1. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res (2006) 4:221–33 10.1158/1541-7786.MCR-05-0261 - DOI - PubMed
    1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell (2010) 140:805–20 10.1016/j.cell.2010.01.022 - DOI - PubMed
    1. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol (2011) 30:16–34 10.3109/08830185.2010.529976 - DOI - PubMed
    1. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet (2001) 357:539–45 10.1016/S0140-6736(00)04046-0 - DOI - PubMed
    1. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol (2007) 7:1271–85 10.1016/j.intimp.2007.05.016 - DOI - PubMed

LinkOut - more resources